Israel's long-range UAV is ready for action

The Air Force's most advanced UAV, which can reach Iran, is back in the air after seven months.

The Israel Air Force's most advanced unmanned aerial vehicle (UAV), the Heron TP, known as the Eitan, is back in the air after being grounded for over seven months. The extraordinary decision to ground all Eitan UAVs was taken after one crashed in late January during a test fight of its payload.

The Eitan is a long-range UAV, capable of reaching Iran, but it did not get far on that January test flight. A rolling breakdown caused a wing to break, resulting in a crash from high altitude, which shattered the UAV in an orchard on the Coastal Plain.

The Air Force and Israel Aerospace Industries Ltd. (IAI) (TASE: ARSP.B1) struggled to understand the cause of the crash to one of the Air Forces' operational workhorses. For years, the Air Force has been expanding its UAV fleet and missions, which now carry out a quarter of all missions - a proportion that is likely to grow.

Examination of the remains found that a wing spar broke under a load for which it was not designed to bear, during the test flight. The crash of the UAV, a state-of-the-art machine in global aviation, was a blow to morale and the pocket, as each Eitan is estimated to cost $5 million.

According to foreign media reports, the Air Force used the Eitan to attack convoys in the Sudan carrying weapons from Iran to terrorist organizations in Gaza. The Eitan's latest intelligence gathering capabilities in difficult conditions, its ability to closely monitor a target, its state-of-the-art observation systems, and ability to stay aloft for over 35 hours while using satellite communications systems, make it relevant under any scenario of a possible Israeli strike on Iran.

Meanwhile, the Air Force is making sure to have the Eitan ready for such a war, and is keeping a low profile about its operational capabilities.

The Eitan's status in the Air Force and its role in building the Air Force's long arm, meant that there was no cutting of corners investigation into the January crash. The Air Force insisted on finding out what went wrong, step by step, mainly to avoid the risk of similar crashes of costly UAVs and disrupting training and operational programs. Such breakdowns should not happen when the Air Force is required to be on high alert to fulfill paramount strategic missions.

The Eitan crashed just one month after a top-secret US UAV, the RQ-170 Sentinel, crashed on a CIA intelligence gathering mission of Iran's nuclear facilities. The RQ-170, whose development was top secret, is used by the US military to track el Qaida terrorists in Afghanistan, and has been nicknamed the Beast of Kandahar.

Two days after Iran announced the crash of the RQ-170, Revolutionary Guards put it on display. The Americans knew that the Iranians would not waste time, and would use reverse engineering to crack one of US Army's most innovative systems.

With this in mind, IAI engineers returned to the drawing boards used to design the Heron a decade earlier to find the cause of the Eitan's crash. During this time, the Eitans sat in Palmachim Air Force Base hangars, and their operators used simulators to keep up the skills.

The Air Force and IAI crash investigation team concluded that a cause of the crash was a childhood illness of the technologies and complex materials used in the Eitan. After the cause of the crash was found, the Eitans were strengthened, but not in a way that would require structural change.

A defense source involved in the program told "Globes", "We succeeded in obtaining absolute certainty that the fault has been fixed. After we located the problem, we understood that the extreme flight conditions of the test flights exposed the Eitan to load dangers that were liable to end in the way that the January test flight ended. Today, the chance of this happening verges on absolute zero."

Published by Globes [online], Israel business news - www.globes-online.com - on August 14, 2012

© Copyright of Globes Publisher Itonut (1983) Ltd. 2012

Ella Kenan  credit: Yossi Cohen A fighter of fake news about Israel

Ella Kenan saw online denial of October 7 happening straightaway. "I realized we had 24 hours, or we were doomed"

Liron Horshi credit: Jonathan Bloom Wiz's talent manager nurtures $1b workforce

Wiz's $32 billion sale to Google was rooted in the cloud security product if offers but could not have been achieved without the quality of its employees built by human resources chief Liron Horshi.

Yoav Shoham  credit: Eyal Izhar Yoav Shoham: AI isn't too smart, it's too dumb

AI21 Labs founder and CEO Prof. Yoav Shoham talks to "Globes" about dubious doomsday predictions, what should really concern us, and what could make Israel a global AI leader.

Record public company profits  credit: Tali Bogdanovsky Profits peak, but reckoning awaits

In what may seem a paradox, profits grew in almost every sector on the Tel Aviv Stock Exchange last year, but the boom was largely fueled by government spending.

Insightec COO and general manager Eyal Zadicario credit: Ness Productions After 25 years of losses Insightec focuses on profit

Insightec COO and general manager Eyal Zadicario tells "Globes" about himself and the Israeli ultrasound company's long battle to change the medical world.

Amit Shaked credit: Tomer Lesher Driven to succeed but balancing ambition with wellbeing

At just 14, cybersecurity company Rubrik VP Amit Shaked began a B.Sc. in Computer Science and Math and mapped out his entire future, which included IDF service in the 8200 unit, and an inevitable huge startup exit.

Advs. Roy Keidar and Netanella Treistman credit: Nicky Westphal AI blind spot startups can no longer afford to ignore

How AI governance can assist startups and enhance their ability to succeed.

Dr. Ola Gutzeit  credit: Ketty Hakim The doctor breaking new ground in fertility

"We know nothing about the female reproductive system," says Dr. Ola Gutzeit of Rambam Hospital. She seeks to change that, and hence change IVF for the better.

Google CEO Sundar Pichai  crediit: Shutterstock Why Google is paying so much for Wiz

Lagging its competitors in cloud and AI, and facing challenges to its core advertising business, Google could be looking to spend its way out of trouble.

Donald Trump speaking on the deck of the USS Gerald R. Ford  at its launch in 2017 credit: Reuters/Jonathan Ernst Houthis between hammer and anvil

President Trump appears determined to end the Houthi threat to shipping, while Iran has abandoned the last active arm of its "axis of resistance."

Prof. Douglas Irwin  credit: Inbal Marmari "We will all be poorer"

Prof. Douglas Irwin, an expert on international trade, talks to "Globes" about the impact of President Trump's tariffs policy, and what Israel can do about it.

Rooftop solar panels credit: Shutterstock Does it pay for homes to install rooftop solar panels?

As the Israeli government steps up efforts to encourage homeowners to produce their own electricity from rooftop panels, "Globes" investigates the advantages and pitfalls.

Dop Elbit banner at London's Allianz HQ credit: Reuters PA Images Violence against Israeli defense cos in UK escalates

"The Sunday Times" has investigated Palestine Action, a radical left-wing group that targets Israeli defense companies, their subsidiaries, and corporations and banks with any connection to Israel.

UnitedHealth founder Richard Burke credit: Ken Easley UnitedHealth founder: US health system is broken

In an exclusive interview Richard Burke talks about the murder of the company's CEO, Donald Trump, his love for Israel, and investment in Israeli startup Korro AI.

Left to right: Karin Goldberg, Einav Laser, Dr. Arseniy Lobov, Dr. Paola Antonello, Dr. Merav Shmueli, and Prof. Yifat Merbl (center in black)  credit: Weizmann Institute Israeli scientists' discovery could lead to new antibiotics

Prof. Yifat Merbl of the Weizmann Institute and her team have found a natural source of anti-microbial substances in the "garbage can" of human cells.

Peter Kash credit: personal photograph Peter Kash confident about cancer cure breakthrough

In Israel for IATI's MIXiii International Life Science and Health-Tech week, the US investor talks about his life science portfolio and the opportunities Israel must seize.

Twitter Facebook Linkedin RSS Newsletters גלובס Israel Business Conference 2018